Cosmetics News and Research

RSS

Two discriminating biological markers found to predict a favorable response to treatment in triple-negative breast cancer

Quinten, a strategic and operational consulting company specializing in the evaluation of biomedical data in the pharmaceutical, biotechnology and cosmetic industries, today announces the identification of two discriminating biological marker candidates which are indicative of a favorable response to treatment in women suffering from triple-negative breast cancer (TNBC).

26 Feb 2013

Study paves way for new prosthetics that connect directly to the nervous system

For an amputee, replacing a missing limb with a functional prosthetic can alleviate physical or emotional distress and mean a return of vocational ability or cosmetics. Studies show, however, that up to 50 percent of hand amputees still do not use their prosthesis regularly due to less than ideal functionality, appearance, and controllability. But Silvestro Micera, of the -cole Polytechnique F-d-rale de Lausanne (EPFL) in Switzerland, is paving the way for new, smart prosthetics that connect directly to the nervous system.

18 Feb 2013

Valor, Oxygen Biotherapeutics enter License and Supply Agreement for Dermacyte

Oxygen Biotherapeutics, Inc., announced today that it has entered into a License and Supply Agreement with the Cosmetics Division of Valor SA of Lausanne, Switzerland, for Dermacyte, a perfluorocarbon based cosmetic product currently manufactured and distributed by Oxygen Biotherapeutics.

11 Feb 2013

UK cosmetic procedures standards announced

The Royal College of Surgeons has published a report on the professional standards, competencies and behaviors expected for physicians, nurses, and dentists performing cosmetic procedures in the UK.

5 Feb 2013

FDA announces federal judge approval of Ben Venue consent decree

The U.S. Food and Drug Administration announced today that a federal judge has approved a consent decree of permanent injunction against Ben Venue Laboratories, Inc., and three of its corporate officers for failing to comply with current good manufacturing practice requirements as required by federal law.

2 Feb 2013

Researchers create CoQ9-deficient mutant mouse model with mitochondrial encephalomyopathy

At three to six months of life, this genetic alteration in mice -similar to that occurred in human- causes a rapid degeneration in the lower limbs to death for cardiac arrest.

30 Jan 2013

140 nations adopt treaty to reduce mercury emissions; Convention will allow use of mercury preservative in vaccines

"More than 140 nations adopted the first legally binding international treaty on Saturday aimed at reducing mercury emissions, after four years of negotiations on ways to set limits on the use of a highly toxic metal," the Associated Press/New York Times reports.

22 Jan 2013

Octapharma receives FDA approval for Octaplas to treat blood clotting disorders

The U.S. Food and Drug Administration today approved Octaplas, a pooled plasma (human) blood product for the replacement of clotting proteins (coagulation factors) in certain medical conditions where patients have insufficient levels.

18 Jan 2013

Low prices for life-saving products may increase perception of risk among consumers

Consumers assume their risk of getting a serious illness is higher when medications are cheaper because they believe that prices for life-saving products are based on need and not profit, according to a new study in the Journal of Consumer Research.

12 Dec 2012

Second annual Dance To Conquer Cancer, Disco Days & Boogie Nights to take place on Mar. 3

The second annual Dance To Conquer Cancer, Disco Days & Boogie Nights, raising funds for the Princess Margaret Cancer Centre, will take place on March 3, 2013, and will feature fitness guru Richard Simmons and three-time Grammy Award winners, the Pointer Sisters!

22 Nov 2012

GVK Biosciences receives AERB approvals to carry out 3H and 14C synthesis activities

GVK Biosciences, Asia's leading Drug Discovery Research & Development organization, has received approvals from the Atomic Energy Regulatory Board (AERB), Government of India, to carry out 3H and 14C synthesis activities.

19 Nov 2012

General guidelines to understand allergic skin conditions

Winter months can bring on the itch as cold weather and indoor heat dry out the skin. It's possible, suggests Chicago allergist, Brian Rotskoff, MD of Clarity Allergy Center, that your winter itch could be caused by more than just the weather. For some people itchy, dry skin is just that, but for others it can be a symptom of atopic dermatitis (eczema), contact dermatitis, or hives (urticaria).

16 Nov 2012

Mastoscopic axillary lymph node dissection ‘preferred choice’

Long-term study findings support the use of mastoscopic axillary lymph node dissection for women with operable breast cancer.

12 Nov 2012

Women more likely to develop spice allergy

Imagine a world where you could never dine away from home, wear makeup, smell of sweet perfumes or eat a large percentage of food on store shelves. According to allergists at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting that is kicking off today in Anaheim, Calif., that is the world for 2 to 3 percent of individuals living with a spice allergy.

8 Nov 2012

Skin safety tips to avoid allergies during Halloween

The effects of using face paints for Halloween can be scary, says Sofia Chaudhry, M.D., assistant professor of dermatology at Saint Louis University.

29 Oct 2012

FDA launches campaign to raise public awareness on prevalence of fraudulent Internet pharmacies

The U.S. Food and Drug Administration today launched a national campaign to raise public awareness about the prevalence of fraudulent Internet pharmacies, which can be dangerous to patient health, and to help consumers make safe purchases.

29 Sep 2012

New computer program predicts most stable structures of nanometer-sized collagen

The human body is proficient at making collagen. And human laboratories are getting better at it all the time. In a development that could lead to better drug design and new treatments for disease, Rice University researchers have made a major step toward synthesizing custom collagen. Rice scientists who have learned how to make collagen - the fibrous protein that binds cells together into organs and tissues - are now digging into its molecular structure to see how it forms and interacts with biological systems.

26 Sep 2012

Consumer Genetics Conference to take place in Boston from Oct. 3-5

The 4th Annual Consumer Genetics Conference, taking place October 3-5 at the Seaport Hotel in Boston, will include a keynote presentation by George Church that will provide a forthright and candid assessment of new sequencing technologies, including the emergence of nanopore DNA sequencing, current trends in personal genomics, and projections on the future path of medical genomics.

24 Sep 2012

FDA warns dietary supplement firms in Colorado and Texas

The U.S. Food and Drug Administration today issued warning letters to PruTect Rx, of Highlands Ranch, Colo., and Trinity Sports Group Inc., of Plano, Texas, for promoting products labeled as dietary supplements with claims to treat concussions and prevent or treat post-concussion syndrome and other neurological disorders.

7 Sep 2012

Pathway describes how alpha hydroxyl acids cause skin exfoliation

A team of investigators from UC Davis and Peking University have discovered a mechanism that may explain how alpha hydroxyl acids (AHAs) -- the key ingredient in cosmetic chemical peels and wrinkle-reducing creams -- work to enhance skin appearance. An understanding of the underlying process may lead to better cosmetic formulations as well as have medical applications.

14 Aug 2012